QPS Locations
QPS has 11 global locations spread across 3 continents, to ensure that we can meet your global study requirements.
NORTH AMERICA
With 4 locations in the USA, QPS has the full range of services covered. Delaware offers Bioanalysis, DMPK and Translational Medicine Labs; Florida supports Clinical Trials from Phase I – IV; Missouri specializes in Phase I Clinical Trials and North Dakota is our Dermal and Transdermal center of excellence.
Let’s discuss your next Clinical Development Program
EUROPE
Locations in North Europe (The Netherlands) and Central Europe (Austria) ensure that our European clients’ needs are covered. The Bioanalytical Lab and Phase I Clinical Trial center in The Netherlands provide perfect balance to the Neurology center of excellence in Austria.
We Are Ready To Meet Your Global Study Requirements
ASIA
Presence in the rapidly growing, ever evolving Asian marketing is critical. QPS offices in India are first class facilities focused on all aspects of generic drug development, including a full bioanalytical lab and clinical trial facilities. QPS is very well established in Taiwan, covering the full complement of lab services and clinical trials management. QPS in China is a newer location, focused on bioanalysis.
China – Shanghai
Lane 600 Tianshan Road,
Shanghai, 200051, China
China – Suzhou
398 Ruoshui Rd, Suzhou Industrial Park,
Suzhou, China
Taiwan (CTPS)
Kangning St., Xizhi Dist.,
New Taipei City 22180,
Taiwan
Let’s discuss your next Clinical Development Program
Custom-Built Research Services
BIOANALYSIS
QPS has full service bioanalytical labs in North America, Europe, China and India.
CLINICAL TRIALS
QPS has full service clinical trial sites in Florida & Missouri in the USA, The Netherlands, Taiwan and India.
TOXICOLOGY
QPS’ organization in Taiwan specializes in Toxicology studies, with legacy operations since 1984.
NEUROLOGY
QPS’ organization in Austria specializes in Neurology, with a broad range of mouse models and late phase clinical studies, and boasts legacy operations since 1999.
